-
EHA Releases Landmark Guidelines, Reshaping the Treatment Landscape for Aggressive Large B-cell Lymphoma丨EHA 2025
Precision Diagnosis and Risk Stratification: The Cornerstone of Individualized Treatment The new EHA guidelines first emphasize the central role of precise diagnosis and comprehensive risk assessment in the management of…
-
Overcoming Venetoclax Resistance in CLL: A Novel BCL2/BCL-xL Dual-Efficacy Degrader Reshapes the Therapeutic Landscape丨EHA 2025
In the high summer of 2025, the highly anticipated European Hematology Association (EHA) Annual Meeting was convened, bringing together top global experts in hematologic oncology to discuss cutting-edge progress and future directions in the field. In the Chronic Lymphocytic Leukemia (CLL) session, Dr. Daisy Diaz, a postdoctoral fellow from MD Anderson Cancer Center in the…
-
EHA 2025: Professor Alberto Orfao on Immune Mechanisms and Diagnostic Breakthroughs in Rare Diseases
As a scholar with a research career spanning over 30 years, Professor Alberto Orfao began his lecture by expressing his profound gratitude. He attributed this honor to the hundreds of…
-
Pujiang Genitourinary Oncology Academic Conference 2025
We are excited to share the upcoming Pujiang Genitourinary Oncology Academic Conference 2025 Webinar taking place on August 27, 2025. 14:00–15:30 (Dublin/London) | 15:00–16:30 CET | 21:00–22:30 CST This online…
-
BJH / JLB | Team of Professors Jianxiang Wang and Shaowei Qiu at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Uncover Novel Mechanisms in t(8;21) AML and Identify Potential Therapeutic Targets
Acute myeloid leukemia, subtype M2b (AML-M2b), was first identified in 1959 by Professor Chongli Yang at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (CAMS), based on clinical features, bone marrow morphology, and cytology. He termed it “subacute granulocytic leukemia.” In 1973, Rowley and colleagues abroad reported the same leukemia…
-
Landmark Collaboration: CACA-LCC and ILCA Forge Strategic Partnership to Advance Global Hepatocellular Carcinoma Research and Treatment
The pre-signing ceremony was graced by the presence of eminent hepatology experts, including Academician Jia Fan, Academician Gaojun Teng, Professor Jian Zhou, Professor Feng Shen, Professor Ming Kuang, Professor Weiping…
-
A Trans-Pacific Meeting of Minds: US–China Collaboration in Urology
On July 10–11, 2025, Professor Steven Campbell, Chair of Urology at West Virginia University, visited the Sun Yat-sen University Cancer Center (SYSUCC) for a two-day academic exchange. His visit brought an international, cutting-edge perspective to SYSUCC’s Department of Urology while also showcasing the department’s achievements to peers worldwide.
Connecting Medical Expertise through Media
